Bríd Smith
Question:215. Deputy Bríd Smith asked the Minister for Health the details of any studies completed by the HSE prior to the decision to discontinue reimbursement support for eye supplements from 2017. [38102/16]
View answerThursday, 1 December 2016
Questions (215, 216, 217, 218, 220)
Bríd Smith
Question:216. Deputy Bríd Smith asked the Minister for Health the number of persons nationally that have applied via the discretionary hardship arrangement for continued support and reimbursements for eye supplements. [38103/16]
View answerBríd Smith
Question:217. Deputy Bríd Smith asked the Minister for Health the number of persons nationally that have successfully received reimbursements via the discretionary hardship fund for eye supplements. [38104/16]
View answerBríd Smith
Question:218. Deputy Bríd Smith asked the Minister for Health the criteria used by the operators of the discretionary hardship fund in assessing persons' requests for continued reimbursement for eye supplements. [38105/16]
View answerBríd Smith
Question:220. Deputy Bríd Smith asked the Minister for Health the projected savings to the HSE of the proposal to remove all eye supplements from its list of drugs qualifying for reimbursements in January 2017. [38107/16]
View answerWritten answers
I propose to take Questions Nos. 215 to 218, inclusive, and 220 together.
Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the administration of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply.